We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Increasing Muscle Mass May Aid Diabetics

By Biotechdaily staff writers
Posted on 21 May 2002
A study has shown that mice genetically altered to promote obesity but lacking the gene that codes for myostatin stay leaner and healthier and do not develop resistance to insulin. More...
Myostatin is a protein known to limit muscle growth. Conducted by researchers at the Johns Hopkins School of Medicine (Baltimore,MD, USA), the study was reported in the March 1, 2002, issue of the Journal of Clinical Investigation.

Previous studies have shown that mice without myostatin become muscle-bound "mighty mice.” Now the researchers show that mice without this protein, even mice that usually become obese, gain much less fat as they age. Regular and obese mice without myostatin gained less fat, as they got older, even though they ate about the same amounts of food as other mice. In fact, "mighty mice” outweighed their counterparts when young, but by 10 months of age weighed the same or less than other mice, which had bulked up with fat.

In people with type 2 diabetes, tissues--especially muscle--stop responding to insulin and therefore do not soak up sugar from the blood. Most current treatment strategies for diabetes target the insulin pathway. The new research suggests that an alternative approach might be to increase muscle mass, which may make the body more efficient at taking up sugar from the blood. The investigators caution that the team is studying genetic knockouts and does not yet know whether it will be possible to block myostatin in adult animals and see similar effects. In any case, myostatin-blocking agents still need to be developed.

"Some normal mice put on a lot of fat as they age and others not as much, but animals lacking myostatin do not put on much fat at all,” says Se Jin Lee, M.D., Ph.D., professor of molecular biology and genetics at Hopkins' Institute for Basic Biomedical Sciences. "This tells me that myostatin might be a useful target for preventing or treating obesity and associated conditions, like diabetes.”




Related Links:
Johns Hopkins

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.